Dendreon Corp fka DNDNQ

[rancherho]

The International Society for the Biological Therapy of Cancer (ISBTC) is one of the world's most highly regarded scientific cancer realted organizations. The NCI's Dr. Steven Rosenberg is the editor of its official publication, the Journal of Immunotherapy, and Dr. James Mule', the chair of the Provenge FDA Advisory Committee, is a co-editor.

The annual meeting of the ISBTC will ne held in Boston in early November. See:http://www.isbtc.org/meetings/am07/complete_schedule.php

Last year, DNDN made a poster presentation on CD54 upregulation. Things are different this year. The last invited speaker at the meeting is DNDN's David Urdal, after which an hour and half is devoted to a "Hot Topic", "The Dendreon Debate". I guess if they really wanted to spice things up a notch, as Emeril might say, they could invite Dr. Richard Pazdur to speak and participate in the debate, providing bodyguards free of charge of course.

These conferences seem to confirm that additional clinical trial results in 2008 should make it an interesting and important year for cancer immunotherapy.